Blinded outcomes and angina assessment of coronary bioresorbable scaffolds: 30-day and 1-year results from the ABSORB IV randomised trial. [electronic resource]
Producer: 20190128Description: 1530-1540 p. digitalISSN:- 1474-547X
- Absorbable Implants
- Acute Coronary Syndrome -- therapy
- Aged
- Biocompatible Materials
- Coronary Artery Disease -- pathology
- Double-Blind Method
- Drug-Eluting Stents
- Everolimus -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Immunosuppressive Agents -- administration & dosage
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Tissue Scaffolds
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.